A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/17/2011	US20110281882 Compositions and Methods for Treating, Controlling, Reducing, or Ameliorating Inflammatory Pain
11/17/2011	US20110281881 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
11/17/2011	US20110281880 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
11/17/2011	US20110281879 Sulfonyl containing compounds as cysteine protease inhibitors
11/17/2011	US20110281878 INHIBITORS OF p38
11/17/2011	US20110281876 Therapeutic agents useful for treating pain
11/17/2011	US20110281875 Inhibitors of IAP
11/17/2011	US20110281874 2-aminopyridine analogs as glucokinase activators
11/17/2011	US20110281873 Pyrimidine Compounds and Methods of Making and Using Same
11/17/2011	US20110281872 Compositions and methods for the prevention and treatment of cancer
11/17/2011	US20110281871 Taar1 ligands
11/17/2011	US20110281870 Novel substituted octahydrocyclopenta[c]pyrrol-4-amines as calcium channel blockers
11/17/2011	US20110281869 Tetrahydroisoquinolines as antimalarial agents
11/17/2011	US20110281868 Indazole inhibitors of kinase
11/17/2011	US20110281867 Compositions and methods of use for tyrosine kinase inhibitors to treat pathogenic infection
11/17/2011	US20110281866 Heterocyclic kinase inhibitors
11/17/2011	US20110281865 Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5- disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
11/17/2011	US20110281864 Pyrido[3,2-d]Pyridazine-2(1H)-One Compounds as p38 Modulators and Methods of Use Thereof
11/17/2011	US20110281863 Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
11/17/2011	US20110281862 Alfa-carboline inhibitors of npm-alk, ret, and bcr-abl
11/17/2011	US20110281861 Thiazopyrimidinones and uses thereof
11/17/2011	US20110281860 Use of quinazoline derivatives for the treatment of viral diseases
11/17/2011	US20110281859 Novel heterocyclic compounds as metap-2 inhibitors
11/17/2011	US20110281858 Aerosol formulation for the inhalation of beta agonists
11/17/2011	US20110281857 Pi3k/mtor kinase inhibitors
11/17/2011	US20110281856 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
11/17/2011	US20110281855 Novel and potent tapentadol dosage forms
11/17/2011	US20110281854 Morpholine compounds
11/17/2011	US20110281853 Compositions and methods for treating or preventing atrial fibrillation
11/17/2011	US20110281852 Pharmaceutical compositions containing berberine for treatment or prevention of weight gain and obesity associated with anti-psychotic drugs
11/17/2011	US20110281851 Biphenyl compounds useful as muscarinic receptor antagonists
11/17/2011	US20110281850 Intracellular kinase inhibitors
11/17/2011	US20110281849 Aryl Indolyl Sulfonamide Compounds and Their Use as 5-HT6 Ligands
11/17/2011	US20110281848 Imidazole compounds having pharmaceutical activity towards the sigma receptor
11/17/2011	US20110281847 Selective estrogen receptor modulators for the treatment of vasomotor symptoms
11/17/2011	US20110281846 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
11/17/2011	US20110281845 Organic compounds
11/17/2011	US20110281844 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
11/17/2011	US20110281843 Substituted indazole derivatives active as kinase inhibitors
11/17/2011	US20110281842 Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases
11/17/2011	US20110281841 Kinase Inhibitors
11/17/2011	US20110281840 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
11/17/2011	US20110281839 Combination therapy for the treatment of bacterial infections
11/17/2011	US20110281838 5-alkynyl-pyrimidines
11/17/2011	US20110281837 3-substituted-6-aryl pyridines
11/17/2011	US20110281836 Silent desensitizers of neuronal NACHR and methods of use thereof
11/17/2011	US20110281835 Novel 3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
11/17/2011	US20110281834 Pharmaceutical Formulations for Iontophoretic Delivery of a Corticosteroid
11/17/2011	US20110281833 Composition for the Treatment of Ear Infections and Method
11/17/2011	US20110281832 Organic compounds
11/17/2011	US20110281831 Novel dermaceutical cream made using sodium fusidate, antifungals and steroids
11/17/2011	US20110281830 Novel dermaceutical cream made using sodium fusidate and steroids
11/17/2011	US20110281829 Novel composition
11/17/2011	US20110281828 Substituted oxazolidinone derivatives
11/17/2011	US20110281827 Compositions, gels and foams with rheology modulators and uses thereof
11/17/2011	US20110281826 Stilbene derivatives for adp-ribosyl cyclase inhibitors
11/17/2011	US20110281825 Inositol pyrophosphates, and methods of use thereof
11/17/2011	US20110281824 Benzofuran derived hiv protease inhibitors
11/17/2011	US20110281823 Pharmaceutical preparation containing an angiotensin II Receptor antagonist, a calcium channel blocker and polyvinyl alcohol
11/17/2011	US20110281822 Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activity
11/17/2011	US20110281821 Modulators of Mitotic Kinases
11/17/2011	US20110281820 Glycosaminoglycans derived from k5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
11/17/2011	US20110281819 Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
11/17/2011	US20110281818 High fructan cereal plants
11/17/2011	US20110281817 Production of hyaluronic acid
11/17/2011	US20110281815 Parental formulations of gemcitabine derivatives
11/17/2011	US20110281814 Methods and compositions for treating breast cancer
11/17/2011	US20110281813 Method of treating c-kit positive relapsed acute myeloid leukemia
11/17/2011	US20110281812 Compounds
11/17/2011	US20110281811 Use Of Leukotriene Inhibitors For Treating Lung Diseases In Prematurely Born Infants
11/17/2011	US20110281810 Composition
11/17/2011	US20110281809 Methods and compositions for rapid treatment of otitis externa
11/17/2011	US20110281808 Composition and Method for Increasing Pre Workout Thermogenics
11/17/2011	US20110281800 Recombinant fusion proteins to growth hormone and serum albumin
11/17/2011	US20110281799 Vascular Endothelial Growth Factor D (VEGF-D) Antibodies and Vectors, and Methods of Uses
11/17/2011	US20110281796 Novel activin receptor and uses thereof
11/17/2011	US20110281795 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
11/17/2011	US20110281794 composition comprising nor-adrenaline and amphetamine for administering to a brain-dead, heart-beating potential organ donor
11/17/2011	US20110281787 Pharmaceutical compositions comprising antisense oligonucleotides and methods of using same
11/17/2011	US20110281725 Citrus oil compositions and methods of use
11/17/2011	US20110281021 Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
11/17/2011	US20110280975 Composition comprising bamboo extract and the compounds isolated therefrom showing activity for the treatment and prevention of inflammatory and blood circulation disease
11/17/2011	US20110280973 Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport
11/17/2011	US20110280970 Absorbable putty-like implants and methods for their use for mechanical hemostasis of bone and for the treatment of osseous defects
11/17/2011	US20110280964 Composition And Method of Treating Hearing Loss
11/17/2011	US20110280954 Compositions and methods for altering stool quality in an animal
11/17/2011	US20110280953 Compositions and methods for altering stool quality in an animal
11/17/2011	US20110280950 Synergistic antioxidant compositions
11/17/2011	US20110280947 Embolization
11/17/2011	US20110280945 Novel method for the preparation of granulates of active constituents, and granulates as obtained
11/17/2011	US20110280941 Compositions of proton pump inhibitors and insulin secretagogues, and methods of their use to treat diabetes
11/17/2011	US20110280940 Di-Vanilloyl And Tri-Vanilloyl Derivatives For Use In Anti-Cancer Therapy
11/17/2011	US20110280939 Oral particle including pseudoephedrine hydrochloride and cetirizine dihydrochloride
11/17/2011	US20110280938 Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
11/17/2011	US20110280934 Increased Expression of Specific Antigens
11/17/2011	US20110280933 Epicatechin compositions and methods
11/17/2011	US20110280932 Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (dmard) and an anti-cancer agent
11/17/2011	US20110280931 Matrix metalloproteinase inhibitor
11/17/2011	US20110280929 Sirna of nf-kb p105 for inhibiting cell proliferation and migration and a composition comprising same
11/17/2011	US20110280925 Dual And Single Layer Dosage Forms

1 ... 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 ... 7860